Your session is about to expire
← Back to Search
Behavioral Intervention
Cognitive-behavioral therapy for Body Dysmorphic Disorder
N/A
Waitlist Available
Led By Angela Fang, Ph.D.
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Men and women, age 18-45
For patients: treatment-seeking individuals presenting with at least moderate levels of social anxiety/body dysmorphic symptoms, and a score of at least 1 SD above the mean on the public self-consciousness scale of the Self-Consciousness Scale- Revised
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 12 weeks later
Awards & highlights
Study Summary
This study is evaluating whether neuroimaging-based markers of maladaptive self-focused processing are better predictors of treatment response to cognitive-behavioral therapy than behavioral markers.
Eligible Conditions
- Body Dysmorphic Disorder
- Social Anxiety Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 12 weeks later
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 12 weeks later
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline clinical symptoms at 12 weeks
Neural activation in the default mode network
Response latencies during Self vs. Other conditions
+1 moreSecondary outcome measures
Structural connectivity within the default mode network
Word valence during Self vs. Other conditions
Trial Design
1Treatment groups
Experimental Treatment
Group I: Cognitive-behavioral therapyExperimental Treatment1 Intervention
Twelve weekly sessions of individual cognitive-behavioral therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive-behavioral therapy
2012
Completed Phase 4
~2450
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,918 Previous Clinical Trials
13,192,746 Total Patients Enrolled
Angela Fang, Ph.D.Principal InvestigatorUniversity of Washington
1 Previous Clinical Trials
41 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger